We are live on
!
Find out more
OCA
OpenArc Corporate Advisory Portfolio holdings
AUM
$8.41B
This Fund
S&P 500
This Quarter
Est. Return
+16.96%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$8.41B
AUM Growth
+$1.42B
(+20%)
Cap. Flow
+$539M
Cap. Flow
% of AUM
6.42%
Top 10 Holdings %
Top 10 Hldgs %
33.46%
Holding
833
New
117
Increased
380
Reduced
255
Closed
44
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$173M |
| 2 |
Vanguard Russell 1000 Value ETF
VONV
|
+$55.3M |
| 3 |
iShares MSCI EAFE Value ETF
EFV
|
+$54M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$34.1M |
| 5 |
BlackRock Flexible Income ETF
BINC
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BAI
iShares A.I. Innovation and Tech Active ETF
BAI
|
+$119M |
| 2 |
PWRD
TCW Transform Systems ETF
PWRD
|
+$57.9M |
| 3 |
iShares US Financial Services ETF
IYG
|
+$24.4M |
| 4 |
Roper Technologies
ROP
|
+$24.1M |
| 5 |
iShares US Consumer Staples ETF
IYK
|
+$16.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.24% |
| 2 | Consumer Discretionary | 5.63% |
| 3 | Healthcare | 3.98% |
| 4 | Industrials | 3.9% |
| 5 | Communication Services | 3.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
GE HealthCare
GEHC
$33.4B
| $302K | ﹤0.01% |
4,711
+561
| +14% | +$36.9K |
|
|
ONC
627
BeOne Medicines Ltd
ONC
$42.6B
| $301K | ﹤0.01% |
1,056
+267
| +34% | +$78.7K |
|
628
Smith & Nephew
SNN
$12.2B
| $300K | ﹤0.01% |
+10,417
| New | +$324K |
|
629
Idexx Laboratories
IDXX
$43.3B
| $300K | ﹤0.01% |
570
+113
| +25% | +$63.4K |
|
630
Pacer US Cash Cows 100 ETF
COWZ
$20.1B
| $300K | ﹤0.01% |
4,823
-31
| -0.6% | -$1.96K |
|
|
WCC
631
WESCO International
WCC
$16.5B
| $300K | ﹤0.01% |
868
-112
| -11% | -$38K |
|
632
Haleon
HLN
$44.8B
| $299K | ﹤0.01% |
32,099
+912
| +3% | +$8.48K |
|
633
Moog Inc Class A
MOG.A
$11.9B
| $299K | ﹤0.01% |
+706
| New | +$241K |
|
634
Global X Robotics & Artificial Intelligence ETF
BOTZ
$3.41B
| $294K | ﹤0.01% |
7,747
| – | – |
|
635
Expeditors International
EXPD
$24.6B
| $294K | ﹤0.01% |
1,803
+271
| +18% | +$41.9K |
|
636
Atlanticus Holdings
ATLC
$1.43B
| $293K | ﹤0.01% |
2,868
-8,500
| -75% | -$689K |
|
637
Fluor
FLR
$6.86B
| $291K | ﹤0.01% |
5,561
-4
| -0.1% | -$196 |
|
638
State Street Materials Select Sector SPDR ETF
XLB
$8.88B
| $291K | ﹤0.01% |
5,721
-286
| -5% | -$14.7K |
|
639
Centrus Energy
LEU
$3.86B
| $290K | ﹤0.01% |
1,730
-552
| -24% | -$103K |
|
640
Healthpeak Properties
DOC
$14.9B
| $289K | ﹤0.01% |
13,511
+3,410
| +34% | +$63.6K |
|
641
SLB Ltd
SLB
$79.1B
| $288K | ﹤0.01% |
6,188
+790
| +15% | +$42.3K |
|
642
Sherwin-Williams
SHW
$85.1B
| $285K | ﹤0.01% |
828
+145
| +21% | +$46.3K |
|
643
EMQQ The Emerging Markets Internet & Ecommerce ETF
EMQQ
$270M
| $284K | ﹤0.01% |
9,090
| – | – |
|
644
PagerDuty
PD
$945M
| $283K | ﹤0.01% |
29,324
+120
| +0.4% | +$908 |
|
645
iShares MSCI Japan ETF
EWJ
$22.6B
| $283K | ﹤0.01% |
3,033
+18
| +0.6% | +$1.63K |
|
646
Sensata Technologies
ST
$6.14B
| $283K | ﹤0.01% |
+5,921
| New | +$268K |
|
647
eBay
EBAY
$47.2B
| $282K | ﹤0.01% |
+2,522
| New | +$269K |
|
648
FormFactor
FORM
$8.42B
| $279K | ﹤0.01% |
+1,745
| New | +$232K |
|
649
Royalty Pharma
RPRX
$27.6B
| $279K | ﹤0.01% |
4,974
+213
| +4% | +$11.1K |
|
|
POWR
650
iShares U.S. Power Infrastructure ETF
POWR
$448M
| $278K | ﹤0.01% |
+9,945
| New | +$272K |
|
Similar funds
HCM
MWM
DKCM
IGAM
FLPIM
MAM
AIM
SBH
OpenArc Corporate Advisory's Q2 2026 Portfolio in Review
As of Q2 2026, OpenArc Corporate Advisory held 833 positions worth $8.41B, up 20% from $6.98B the previous quarter. Its ten largest holdings account for 33% of the portfolio.
OpenArc Corporate Advisory deployed $539M of net new capital in Q2 2026, opening 117 new positions and adding to 380 existing holdings. Its largest new stake was iShares Russell 1000 ETF: 437,245 shares worth $179M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares A.I. Innovation and Tech Active ETF, an estimated $119M trimmed.
- OpenArc Corporate Advisory's largest Q2 2026 buy was iShares Russell 1000 ETF: 437,245 shares worth $179M.
- OpenArc Corporate Advisory added most to Vanguard Russell 1000 Value ETF in Q2 2026, an estimated $55.3M increase.
- OpenArc Corporate Advisory's biggest Q2 2026 reduction was iShares A.I. Innovation and Tech Active ETF, cutting an estimated $119M.
- OpenArc Corporate Advisory fully exited Kiniksa Pharmaceuticals in Q2 2026, selling an estimated $2.33M.
- OpenArc Corporate Advisory's ten largest holdings make up 33% of its $8.41B portfolio in Q2 2026.
- OpenArc Corporate Advisory opened 117 new positions and closed 44 in Q2 2026.
- OpenArc Corporate Advisory's portfolio value rose 20% quarter-over-quarter to $8.41B.
Based on OpenArc Corporate Advisory's 13F filing for Q2 2026, filed 5 Aug 2026.